Prolonged remission was observed in 72% of patients with systemic lupus erythematosus (SLE) who were treated with a consistent 200 mg daily dose of hydroxychloroquine. The mean weight-adjusted ...
Primary outcome was progression to SLE, as defined by the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria. Mean follow-up was 7 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback